The future of artificial intelligence in digital pathology - results of a survey across stakeholder groups

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Céline N Heinz - , University Hospital Aachen (Author)
  • Amelie Echle - , University Hospital Aachen (Author)
  • Sebastian Foersch - , University Medical Center Mainz (Author)
  • Andrey Bychkov - , Kameda Medical Center (Author)
  • Jakob Nikolas Kather - , Else Kröner Fresenius Center for Digital Health, University Hospital Aachen, National Center for Tumor Diseases (NCT) Heidelberg, Leeds Teaching Hospitals NHS Trust, University of Leeds (Author)

Abstract

AIMS: Artificial intelligence (AI) provides a powerful tool to extract information from digitised histopathology whole slide images. During the last 5 years, academic and commercial actors have developed new technical solutions for a diverse set of tasks, including tissue segmentation, cell detection, mutation prediction, prognostication and prediction of treatment response. In the light of limited overall resources, it is presently unclear for researchers, practitioners and policymakers which of these topics are stable enough for clinical use in the near future and which topics are still experimental, but worth investing time and effort into.

METHODS AND RESULTS: To identify potentially promising applications of AI in pathology, we performed an anonymous online survey of 75 computational pathology domain experts from academia and industry. Participants enrolled in 2021 were queried about their subjective opinion on promising and appealing subfields of computational pathology with a focus upon solid tumours. The results of this survey indicate that the prediction of treatment response directly from routine pathology slides is regarded as the most promising future application. This item was ranked highest in the overall analysis and in subgroups by age and professional background. Furthermore, prediction of genetic alterations, gene expression and survival directly from routine pathology images scored consistently high throughout subgroups.

CONCLUSIONS: Together, these data demonstrate a possible direction for the development of computational pathology systems in clinical, academic and industrial research in the near future.

Details

Original languageEnglish
Pages (from-to)1121-1127
Number of pages7
JournalHistopathology
Volume80
Issue number7
Publication statusPublished - Jun 2022
Peer-reviewedYes

External IDs

Scopus 85129878621

Keywords

Keywords

  • Artificial Intelligence, Humans, Mutation, Neoplasms/diagnosis